A 20-year-old male soldier, with a history of a series of episodes of vomiting 22 days ago, presented with a central scotoma in his left eye. His visual acuity was hand movements OS. Fundus examination revealed a boat-shaped large premacular hemorrhage, and spectral-domain optical coherence tomography demonstrated a sub-internal limiting membrane (ILM) hemorrhage [ Fig. 1 ]. Given the classical clinical presentation, a diagnosis of Valsalva retinopathy was made.
Nd:YAG laser was applied in a single shot to the ILM surface, beginning at 1.7 mJ and titrated in 0.2-0.3 mJ steps, without effect. Finally, a single shot at 4.8 mJ led to successful photodisruption and some blood was noted flowing through the ILM opening. However, drainage was minimal due to clot formation. When the second shot at the same energy was applied at a different location on the dependent part of ILM covering thick hemorrhage to protect the underlying retina, blood began to drain smoothly into vitreous cavity [ Fig. 2 ]. Four days postprocedure, the corrected vision was 20/25 with near-complete clearing of the premacular region. Three weeks later, his vision was 20/20 with further clearing of the vitreous hemorrhage [ Fig. 3 ].
Discussion
Nd:YAG membranotomy is a valuable treatment option for sub-ILM hemorrhage. [1] [2] [3] A duration of over 3 weeks is known to be a critical factor for failure of clearance of sub-ILM hemorrhage. [4, 5] In our patient with a 22-day-old hemorrhage, the responses to the two laser shots were totally different. It might be because the degree of blood clot formations was not homogenous within the hemorrhage. Some cumulative effect of the energy delivered by two laser shots might also have contributed to the disruption of partly coagulated blood, resulting in its successful drainage. 
Conclusion
An additional laser shot successfully evacuated a sub-ILM hemorrhage. This result of different responses to laser shots could be taken into consideration while managing a sub-ILM hemorrhage of over 3 weeks' duration.
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